DUBLIN–(BUSINESS WIRE)–

Research and Markets (http://www.researchandmarkets.com/research/k4b4f3/global_multiple_sc) has announced the addition of the “Global Multiple Sclerosis Drug Pipeline Capsule – 2012″ report to their offering.

This report is an outline of all the key research and development (R&D) activities of the global Multiple Sclerosis drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the Multiple Sclerosis drug market is thoroughly covered by company and licensee with the deal summary.

Key Features of the Report:

– Multiple Sclerosis: Overview

– Multiple Sclerosis Drug Pipeline Overview

– Multiple Sclerosis Phase 3 Clinical Trial Drug Pipeline Insights

– Multiple Sclerosis Phase 2 Clinical Trial Drug Pipeline Insights

See the original post here:
Research and Markets: Global Multiple Sclerosis Drug Pipeline Capsule – 2012

Source:
http://www.longevitymedicine.tv/feed/